Related Experiment Videos
Summary
High adherence to statins and dual antiplatelet therapy (DAPT) was observed in patients post-percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS). However, PCI procedures were often delayed, indicating a need for improved patient routing.
Area of Science:
- Cardiology
- Interventional Cardiology
- Public Health
Background:
- Acute coronary syndrome (ACS) requires timely intervention.
- Percutaneous coronary intervention (PCI) is a key treatment for ACS.
- Therapeutic adherence post-PCI is crucial for long-term outcomes.
Purpose of the Study:
- To evaluate patient adherence to statin and dual antiplatelet therapy (DAPT) after PCI for ACS.
- To identify potential delays in PCI procedures for ACS patients in Udmurtia.
Main Methods:
- Retrospective analysis of 127 ACS patient case histories who underwent PCI in 2015.
- Questioning of 95 patients regarding statin and DAPT use up to two years post-PCI.
- Inclusion criteria: age 25-75, confirmed ACS, first-time coronary stenting.
Main Results:
- High adherence rates: 83% regularly took statins, and 85% received DAPT for at least one year post-PCI.
- PCI procedures were frequently delayed, often exceeding 6 hours from symptom onset.
Conclusions:
- Therapeutic adherence to statins and DAPT following PCI for ACS is high.
- Significant delays in PCI for ACS patients in Udmurtia were noted.
- Improved patient routing to PCI centers is recommended for timely myocardial revascularization.